Cannabis use and non-clinical dimensions of psychosis in university students presenting to primary care

Acta Psychiatrica Scandinavica

Volumn 123, Issue 1, 2011, Pages 21-27

  Skinner, R ^a   Conlon, L ^a   Gibbons, D ^a   McDonald, C ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Age of onset; Cannabis; Community Assessment of Psychic Experiences; Psychotic symptoms

Indexed keywords

CANNABIS;

ADOLESCENT; ADULT; ARTICLE; CANNABIS ADDICTION; COMMUNITY ASSESSMENT OF PSYCHIC EXPERIENCES; CONFOUNDING VARIABLE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; POSITIVE SYNDROME; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOSIS; QUESTIONNAIRE; RISK; SELF REPORT; UNIVERSITY STUDENT;

AGE OF ONSET; ANXIETY; DEPRESSION; EMPIRICAL RESEARCH; HUMANS; IRELAND; MARIJUANA ABUSE; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOSES, SUBSTANCE-INDUCED; RISK FACTORS; SELF REPORT; SEVERITY OF ILLNESS INDEX; STUDENTS; TIME;

EID: 78650035327     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2010.01546.x     Document Type: Article

References (30)

1. Hope A, Dring C, Dring J. College Lifestyle and Attitudinal National (CLAN) Survey. Dublin: Health Promotion Unit, 2005.
2. Verdoux H, Sorbara F, Gindre C, Joel D, Swedenson D, Van Os J. Cannabis use and dimensions of psychosis in a nonclinical population of female subjects. Schizophr Res 2002;59:77-84.
3. Gledhill-Hoyt J, Lee H, Striate J, Wechsler H. Increased use of marijuana and other illicit drugs at US colleges in the 1990s: results of three national surveys. Addiction 2000;95:1655-1667.
4. Amar B, Potvin S. Cannabis and psychosis: what is the link? J Psychoactive Drugs 2007;39:131-142.
5. Semple D, Mcintosh A, Lawrie S. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 2005;19:187-194.
6. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt T. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002;325:1212-1213, 99:1333-1341.
7. Stefanis NC, Delespaul P, Henquet C, Bakuola C, Stefanis CN, Van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004;99:1333-1341.
8. Konings M, Henquet C, Maharajh HD, Hutchinson G, Van Os J. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad. Acta Psychiatr Scand 2008;118:209-213.
9. Andreasson S, Allbeck P, Engstrom A et al. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987;2:1483-1486.
10. Van Os J, Bak M, Hanssen M, Biji RV, De Graff R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002;156:319-327.
11. Van Os J, Hanssen M, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms. An urban-rural comparison. Arch Gen Psychiatry 2001;58:663-668.
12. Johns LC, Cannon M. Prevalence and correlates of self-reported psychotic symptoms in the British population. Br J Psychiatry 2004;185:298-305.
13. Stefanis NC, Hanssen M, Smirnis NK et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med 2002;32:347-358.
14. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370.
15. Hides L, Lubman D, Buckby J et al. The association between early cannabis use and psychotic-like experiences in a community adolescent sample. Schizophr Res 2009;112:130-135.
16. Moore T, Zammit S, Lingford-Hughes A et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007;370:319-328.
17. Henquet C, Krabbendam L, Spauwen J et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005;330:11.
18. Morrison PD, Murray RM. From real-world events to psychosis: the emerging neuropharmacology of delusions. Schizophr Bull 2009;35:668-674.
19. Howlett AC, Breivogel CS, Childers CR. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 2004;47:345-358.
20. D'souza DC, Sewell RA, Ranganathan M. Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci 2009;259:413-431.
21. Gorriti MA, Rodriguez De Fonseca F, Navarro M, Paloma T. Chronic delta-9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamines in rats. Eur J Pharmacol 1999;365:133-142.
22. D'sousa DC, Perry E, Macdougall L et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 2004;29:1558-1572.
23. Cadogen AK, Alexander S, Boyde E, Kendall D. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. J Neurochem 1997;69:1131-1137.
24. Steffans M, Engler C, Zentner J, Feuerstein T. Cannabinoid CBI receptor-mediated modulation of evoked dopamine release and of adenyl cyclase activity in the human neocortex. Br J Pharmacol 2004;141:1193-1202.
25. Caspi A, Moffitt T, Cannon M et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-o-methyltransferase gene: longitudinal evidence of a gene × environment interaction. Biol Psychiatry 2005;57:1117-1127.
26. Di Forti M, Lappin JM, Murray RM. Risk factors for schizophrenia - all roads lead to dopamine. Eur Neuropsychpharmacol 2007;17(Suppl. 2):S101-S107.
27. Schneider M, Koch M. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 2003;28:1760-1769.
28. Arnone D, Barrick TR, Chengappa S et al. Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics. Neuroimage 2008;41:1067-1074.
29. Bava S, Frank LR, Mcquenny T et al. Altered white matter microstructure in adolescent substance users. Psychiatry Res 2009;173:228-237.
30. Wilson W, Mathew R, Turkington T et al. Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. J Addict Dis 2000;19:1-22.